Recurrence_rates_of_treated_basal_cell_carcinomas._Part_1:_Overview._This_is_the_first_article_in_a_series_reviewing_the_extensive_experience_of_the_Oncology_Section_of_the_Skin_and_Cancer_Unit,_from_1955_through_1982,_with_5755_basal_cell_carcinomas_(BCCs)_treated_by_curettage-electrodesiccation,_surgical_excision,_or_x-ray_therapy._Recurrence_rates_were_calculated_by_three_methods_for_each_of_the_treatment_modalities:_1)_by_the_raw_recurrence_rate_method;_2)_by_the_"strict"_5-year_recurrence_rate_method;_and_3)_by_modification_of_the_life-table_method._Our_analyses_show_that_the_last_method_best_approximates_the_true_recurrence_rate._Primary_(previously_untreated)_BCCs_had_a_5-year_recurrence_rate_of_10.6%_(standard_error_0.6%),_and_previously_treated_BCCs_had_a_rate_of_15.4%_(standard_error_1.3%)_(P_=_.0002)._The_greatest_risk_for_recurrence_of_treated_primary_BCCs_occurred_1_to_4_years_after_therapy._It_is_concluded_that_recurrence_rates_of_primary_BCCs_should_be_reported_separately_from_those_of_previously_treated_BCCs_and_that_the_modified_life-table_method_is_best_suited_to_calculate_5-year_recurrence_rates.